ICON names global head of clinical research services

ICON announced that Dr Steve Cutler will join the company as group president, clinical research services.

Dr Cutler has over 23 years’ experience within the pharmaceutical and CRO industry and joins ICON from Kendle where he held the position of chief executive officer, having previously served as Kendle’s chief operating officer. Prior to Kendle, Dr Cutler spent 14 years with Quintiles where he served as senior vice president, global project management; senior vice president, clinical, medical and regulatory; senior vice president, project management - Europe; and vice president, oncology - Europe as well as regional leadership positions in South Africa and Australia.

Prior to joining Quintiles Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. He holds a BSc and a PhD from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).

ICON also announced that Alan Morgan, the former group president, clinical research services, has resigned from his position and will leave the organisation at the end of April 2012 to pursue other opportunities.

Commenting on the organisational changes, Ciaran Murray CEO of ICON said: “We are delighted to welcome Steve to ICON. He is joining us at a time when we are building the foundations for long-term sustainable growth and his experience and proven leadership capabilities will be important as we continue to enhance our position as the global CRO partner of choice for the Biopharma industry. I would also like to thank Alan for his commitment to ICON and acknowledge the contribution he has made to our organisation. I wish him every success in the future.”